Pharmaron's DMPK Insights Podcast Episode #8: “It’s ‘All-go’ with Oligos: Challenges and Opportunities in LC-MS of Therapeutics.”
Explore the latest episode of Pharmaron's DMPK Insights Podcast Series: “It’s ‘All-go’ with Oligos: Challenges and Opportunities in LC-MS of Therapeutics.”Join experts Robert MacNeill, Professor Michael Bartlett and Dr. Guilherme (Gui) Guimaraes as they delve into the dynamic world of oligonucleotide LC-MS. Discover the key challenges, the critical importance of sensitivity in these assays, and the innovative analytical approaches and technologies being developed…
Menopause care provider Minter Hormone Health wins Femtech and Women’s Health competition
The Femtech & Women’s Health edition of ‘Discovery Spark’ supports early stage businesses working to close the gender health gap
Sandwich, Kent, UK / 15th July 2024 / Discovery Park has announced Minter Hormone Health as the winner of the Discovery Spark FemTech and Women’s Health Prize, following a competitive pitch process to three expert panels.
The Women’s Health startup will now receive a prize package worth over £50K, including one year of lab or office space at Discovery…
Anglia Innovation Partnership, the campus management organisation at Norwich Research Park, hosted its latest Enterprise Tuesday event on Tuesday 11 June at the John Innes Conference Centre, showcasing novel technology platforms and debating the value of ‘science push and industry pull’ activity in the cluster.
The event entitled ‘Research and Technology Platforms Open for Innovative Business’ presented case studies to explain how the specialist facilities were created, at the campus, how they are used in publicly funded research, on the campus, and their current and future potential…
CCDC Scientist Awarded Prestigious BACG Young Scientists Award
Dr Pietro Sacchi Wins the Award for Ground-Breaking Work Providing Practical Solutions to Long-Standing Challenges in Drug Development and Manufacturing
Cambridge, UK – 12 July 2024 – We are pleased to announce that Dr Pietro Sacchi, Research and Application Scientist at the CCDC, has been awarded the British Association for Crystal Growth (BACG) Young Scientists Award for his exceptional research on the HIV drug ritonavir.
The BACG Young Scientists Award is granted annually to a candidate who has made the most significant…
The pharmaceutical landscape is evolving rapidly, and staying ahead requires a deep understanding of the current trends and challenges. This comprehensive report provides a critical analysis of the drug development industry, focusing on the health of pipelines, the strategic focus of biotechs and pharmacos, and the capacity of regulators like the FDA to manage the influx of novel therapies.
Download now.
AMSBIO offers a wide range of products to support skeletal muscle cell culture enabling you to streamline your modelling process in vitro.
Skeletal muscle accounts for 30-40% of the weight in a healthy individual. However, it is also a key site for insulin-stimulated glucose disposal and often where insulin resistance in obesity arises. Human primary cultured skeletal myoblasts can directly reflect a patient's metabolic phenotype because many of the signaling pathways are maintained intact. Therefore, modelling human skeletal muscle in vitro …
Read Article:
https://sourcebioscience.com/what-are-the-four-steps-of-next-gen-sequen…
With the new Labour government pledging to 'build an NHS fit for the future', an injection of money, whilst welcome, will not be enough - it must be rolled out in a measured and integrated way that works more closely with the private sector in order to make a real difference, says RSM UK.
Clive Makombera, partner and head of NHS at the leading audit, tax and consulting firm RSM UK, comments: 'Labour’s plans for the NHS imply seismic changes in workforce performance and culture. The government has set itself the challenge of clearing waiting times for elective treatment of…
Read July's eNews here
Featuring:
Tony Jones intro following ON Helix 2024
Simple Steps for a Greener Life Sciences Lab
The Evolving Life Sciences Landscape
Deal-making for Cell and Gene Therapy Companies: Insights from One Nucleus’ Panel Event
A Truly Golden Triangle for Life Sciences
Building the Right Environment for Life Science Companies
Beyond Borders: EY Biotechnology Report 2024
Presentation in Boston at 9th Microbiome Movement Drug Development Summit, 10-12 July 2024
Cambridge, UK – 9 July 2024: Microbiotica, a biopharma company developing a pipeline of orally-delivered precision microbiome medicines called live biotherapeutic products (LBPs), announces that Adam Wilkinson, its Vice President of Pre-Clinical Development, will present an overview of the company’s successful product manufacturing campaigns ahead of its forthcoming melanoma and ulcerative colitis clinical studies at the 9th Microbiome Movement Drug Development Summit, on 11 July, in Boston, USA,…